VCP
NEO icon

Verus Capital Partners’s NeoGenomics NEO Stock Holding History

Verus Capital Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$1K Sell
20
-380
-95% -$11.4K ﹤0.01% 1417
2019
Q4 		$12K Buy
+400
New +$9.53K ﹤0.01% 1061

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KFO
Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Verus Capital Partners's NEO Position: Q1 2020 in Review

Verus Capital Partners reduced its NeoGenomics (NEO) stake by 95% in Q1 2020, selling an estimated $11.4K and leaving 20 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1417.

Verus Capital Partners first reported a position in NEO in Q4 2019 and has held it in 2 quarters since. The position peaked at $12K in Q4 2019. 272 funds tracked by Wall St. Rank hold NEO as of Q1 2020.

  • Verus Capital Partners held 20 shares of NeoGenomics worth $1K as of Q1 2020.
  • Verus Capital Partners sold 380 NeoGenomics shares in Q1 2020, an estimated $11.4K.
  • NeoGenomics made up ﹤0.01% of Verus Capital Partners's portfolio in Q1 2020, its #1417 holding.
  • Verus Capital Partners first reported a position in NeoGenomics in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's NeoGenomics position peaked at $12K in Q4 2019.
  • 272 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.